TRISALUS LIFE SCIENCES ($TLSI) posted quarterly earnings results for Q1 2026 on Tuesday, May 12th. The company reported earnings of -$0.14 per share, beating estimates of -$0.16 by $0.02. The company also reported revenue of $8,900,000, missing estimates of $10,649,004 by $-1,749,004.
Stock price change since market close: -4.05%
You can see Quiver Quantitative's $TLSI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TRISALUS LIFE SCIENCES Insider Trading Activity
TRISALUS LIFE SCIENCES insiders have traded $TLSI stock on the open market 20 times in the past 6 months. Of those trades, 6 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $TLSI stock by insiders over the last 6 months:
- MICHAEL P STANSKY has made 2 purchases buying 361,098 shares for an estimated $1,480,501 and 0 sales.
- MARY T SZELA (CEO and President) has made 1 purchase buying 30,487 shares for an estimated $124,996 and 2 sales selling 20,302 shares for an estimated $79,382.
- WILLIAM VALLE purchased 30,487 shares for an estimated $124,996
- GARY B. GORDON purchased 9,756 shares for an estimated $39,999
- DAVID PATIENCE (Chief Financial Officer) purchased 3,657 shares for an estimated $14,993
- JENNIFER STEVENS (Chief Regulatory Officer) has made 0 purchases and 3 sales selling 3,530 shares for an estimated $14,509.
- RICHARD MARSHAK (Chief Commercial Officer) has made 0 purchases and 3 sales selling 3,457 shares for an estimated $14,209.
- JODI DEVLIN (Chief of Clinical Operations) has made 0 purchases and 3 sales selling 3,207 shares for an estimated $13,171.
- BRYAN F. COX (Chief of Research) has made 0 purchases and 3 sales selling 3,184 shares for an estimated $13,085.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
TRISALUS LIFE SCIENCES Hedge Fund Activity
We have seen 41 institutional investors add shares of TRISALUS LIFE SCIENCES stock to their portfolio, and 17 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 1,437,960 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,751,840
- BLACKROCK, INC. added 746,472 shares (+94.7%) to their portfolio in Q4 2025, for an estimated $5,210,374
- WEALTHCARE ADVISORY PARTNERS LLC removed 643,740 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,574,960
- VANGUARD GROUP INC added 371,132 shares (+32.0%) to their portfolio in Q4 2025, for an estimated $2,590,501
- MORGAN STANLEY added 347,278 shares (+1931.8%) to their portfolio in Q4 2025, for an estimated $2,424,000
- PERKINS CAPITAL MANAGEMENT INC added 230,101 shares (+inf%) to their portfolio in Q1 2026, for an estimated $920,404
- GEODE CAPITAL MANAGEMENT, LLC added 196,752 shares (+35.5%) to their portfolio in Q4 2025, for an estimated $1,373,328
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
